Infliximab trough levels and anti-drug antibodies after induction predict long-term clinical remission in infliximab-treated patients with inflammatory bowel disease

被引：0
|
作者：
Bodini, G. [1 ]
Del Nero, L. [1 ]
Giannini, E. G. [1 ]
Tolone, S. [2 ]
De Bortoli, N. [3 ]
Anjali, J. [4 ]
Baldissarro, I. [1 ]
Savarino, V. [1 ]
Savarino, E. [5 ]
机构：
[1] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy
[2] Univ Naples 2, Dept Surg, Naples, Italy
[3] Univ Pisa, Dept Internal Med, Gastroenterol Unit, Pisa, Italy
[4] Prometheus Labs, Dept Res & Dev, San Diego, CA USA
[5] Univ Padua, Dept Surg Oncol & Gastroenterol, Gastroenterol Unit, Padua, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P607
引用
收藏
页码：S408 / S409
页数：2
相关论文
共 50 条
  • [1] INFLIXIMAB TROUGH LEVELS AND ANTI-DRUG ANTIBODIES AFTER INDUCTION AS PREDICTIVE FACTORS OF LONG TERM CLINICAL REMISSION
    Bodini, G.
    Del Nero, L.
    Giannini, E.
    De Maria, C.
    Baldissarro, I
    Savarino, V
    Savarino, E.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E163 - E163
  • [2] Infliximab trough levels and persistent vs transient antibodies measured early after induction predict long-term clinical remission in patients with inflammatory bowel disease
    Bodini, Giorgia
    Giannini, Edoardo G.
    Savarino, Vincenzo
    Del Nero, Lorenzo
    Lo Pumo, Sara
    Brunacci, Matteo
    De Bortoli, Nicola
    Jain, Anjali
    Tolone, Salvatore
    Savarino, Edoardo
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (05) : 452 - 456
  • [3] Post induction infliximab trough levels predict long-term endoscopic remission in paediatric patients with inflammatory bowel disease
    van Hoeve, K.
    Dreesen, E.
    Hoffman, I.
    Ferrante, M.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S362 - S363
  • [4] INCIDENCE AND CLINICAL OUTCOME OF ANTI-DRUG ANTIBODIES IN INFLIXIMAB-TREATED PATIENTS
    Bartoli, F.
    Fiori, G.
    Galluccio, F.
    Petroni, G.
    Pratesi, S.
    Matucci, A.
    Vultaggio, A.
    Nacci, F.
    Nencini, F.
    Maggi, E.
    Matucci-Cerinic, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 514 - 514
  • [5] Infliximab trough levels for remission induction and long term therapy management of inflammatory bowel disease
    Perdigoto, D.
    Portela, F.
    Ferreira, M.
    Mendes, S.
    Freire, P.
    Ferreira, M.
    Lopes, S.
    Tome, L.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S386 - S386
  • [6] Discriminating Between Response Types in Infliximab-Treated Patients With Crohn's Disease: Sensitivity and Specificity of Combined Assessment of Infliximab Trough Levels and Anti-Drug Antibodies
    Steenholdt, Casper
    Thomsen, Ole O.
    Brynskov, Jorn
    Bendtzen, Klaus
    Ainsworth, Mark A.
    GASTROENTEROLOGY, 2010, 138 (05) : S687 - S688
  • [7] Clinical Use of Infliximab Trough Levels and Antibodies to Infliximab in Pediatric Patients With Inflammatory Bowel Disease
    Merras-Salmio, Laura
    Kolho, Kaija-Leena
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2017, 64 (02): : 272 - 278
  • [8] Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease
    Pariente, Benjamin
    de Chambrun, Guillaume Pineton
    Krzysiek, Roman
    Desroches, Marine
    Louis, Gauthier
    De Cassan, Chiara
    Baudry, Clotilde
    Gornet, Jean-Marc
    Desreumaux, Pierre
    Emilie, Dominique
    Colombel, Jean-Frederic
    Allez, Matthieu
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (07) : 1199 - 1206
  • [9] INFLIXIMAB SERUM LEVELS DURING INDUCTION PREDICT LONG-TERM ENDOSCOPIC REMISSION IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
    van Hoeve, Karen
    Dreesen, Erwin
    Hoffman, Ilse
    Ferrante, Marc
    Vermeire, Severine
    GASTROENTEROLOGY, 2020, 158 (06) : S968 - S968
  • [10] Disappearance of anti-drug antibodies to infliximab and adalimumab after addition of an immunomodulator in patients with inflammatory bowel disease
    Strik, A.
    van den Brink, G.
    Ponsioen, C.
    Mathot, R.
    Lowenberg, M.
    D'Haens, G.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S69 - S70
12345